Micrometastatic node-positive breast cancer: Long-term outcomes and identification of high-risk subsets in a large population-based series

Annals of Surgical Oncology

Volumn 17, Issue 8, 2010, Pages 2138-2146

  Truong, Pauline T ^a,b   Lesperance, Mary ^c   Li, Karen Hui ^c   MacFarlane, Robyn ^a,b   Speers, Caroline H ^a   Chia, Stephen ^a,b  

^a BRITISH COLUMBIA CANCER AGENCY   (Canada)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

^c UNIVERSITY OF VICTORIA   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; AGED; ARTICLE; BREAST CANCER; CANCER RISK; CANCER SURVIVAL; HUMAN; LONG TERM CARE; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MICROMETASTASIS; PROGNOSIS; SENTINEL LYMPH NODE BIOPSY; BREAST TUMOR; CASE CONTROL STUDY; FEMALE; FOLLOW UP; KAPLAN MEIER METHOD; LYMPH NODE; LYMPH NODE DISSECTION; MIDDLE AGED; MORTALITY; PATHOLOGY; PROPORTIONAL HAZARDS MODEL; REGRESSION ANALYSIS; RISK ASSESSMENT; SURGERY; SURVIVAL; VERY ELDERLY; YOUNG ADULT;

ADULT; AGED; AGED, 80 AND OVER; BREAST NEOPLASMS; CASE-CONTROL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; KAPLAN-MEIERS ESTIMATE; LYMPH NODE EXCISION; LYMPH NODES; LYMPHATIC METASTASIS; MIDDLE AGED; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; REGRESSION ANALYSIS; RISK ASSESSMENT; SURVIVAL ANALYSIS; YOUNG ADULT; KAPLAN-MEIER ESTIMATE;

EID: 77954955727     PISSN: 10689265     EISSN: 15344681     Source Type: Journal    
DOI: 10.1245/s10434-010-0954-y     Document Type: Article

References (35)

1. Hawes D, Neville AM, Cote RJ. Detection of occult metastasis in patients with breast cancer. Semin Surg Oncol. 2001;20:312-8. (Pubitemid 33044275)
2. Cronin-Fenton DP, Ries LA, Clegg LX, Edwards BK. Rising incidence rates of breast carcinoma with micrometastatic lymph node involvement. J Natl Cancer Inst. 2007;99:1044-9.
3. Grabau D. Breast cancer patients with micrometastases only: is a basis provided for tailored treatment? Surg Oncol. 2008;17:211-7.
4. Wada N, Imoto S. Clinical evidence of breast cancer micrometastasis in the era of sentinel node biopsy. Int J Clin Oncol. 2008;13:24-32.
5. American Joint Committee on Cancer. Breast. In: AJCC cancer staging manual, 5th edition. Lippincott-Raven, Philadelphia; 1997.
6. Huvos AG, Hutter RV, Berg JW. Significance of axillary macrometastases and micrometastases in mammary cancer. Ann Surg. 1971;173:44-6.
7. Attiyeh FF, Jensen M, Huvos AG, Fracchia A. Axillary micro-metastasis and macrometastasis in carcinoma of the breast. Surg Gynecol Obstet. 1977;144:839-42.
8. Fisher ER, Palekar A, Rockette H, Redmond C, Fisher B. Pathologic findings from the National Surgical Adjuvant Breast Project (Protocol No. 4). V. Significance of axillary nodal micro-and macrometastases. Cancer. 1978;42:2032-8. (Pubitemid 9055972)
9. Rosen PP, Saigo PE, Braun DW, Weathers E, Fracchia AA, Kinne DW. Axillary micro-and macrometastases in breast cancer: prognostic significance of tumor size. Ann Surg. 1981;194:585-91.
10. International (Ludwig) Breast Cancer Study Group. Prognostic importance of occult axillary lymph node micrometastases from breast cancers. Lancet. 1990;335:1565-8.
11. Cummings MC, Walsh MD, Hohn BG, et al. Occult axillary lymph node metastases in breast cancer do matter: results of 10-year survival analysis. Am J Surg Pathol. 2002;26:1260-95.
12. Chen SL, Hoehne FM, Giulano AE. The prognostic significance of micrometastases in breast cancer: a SEER population-based analysis. Ann Surg Oncol. 2007;14:3378-84.
13. Colleoni M, Rotmensz N, Peruzzotti G, et al. Size of breast cancer metastases in axillary lymph nodes: clinical relevance of minimal lymph node involvement. J Clin Oncol. 2005;23:1379-89.
14. Truong PT, Vinh-Hung V, Cserni G, Woodward WA, Tai P, Vlastos G. The number of positive nodes and the ratio of positive to excised nodes are significant predictors of survival in women with micrometastatic node-positive breast cancer. Eur J Cancer 2008;44:1670-7.
15. de Boer M, van Deurzen C H M, van Dijck J, et al. Micrometastases or isolated tumor cells and the outcome of breast cancer. N Engl J Med. 2009;361:653-63.
16. Tan LK, Giri D, Hummer AJ, et al. Occult axillary node metastases in breast cancer are prognostically significant: results in 368 node-negative patients with 20-year follow-up. J Clin Oncol. 2008;26:1803-9.
17. Reed J, Rosman M, Verbanac KM, Mannie A, Cheng Z, Tafra L. Prognostic implications of isolated tumor cells and micrometastases in sentinel nodes of patients with invasive breast cancer: 10-year analysis of patients enrolled in the prospective East Carolina University/Anne Arundel Medical Center Sentinel Node Multi-center Study. J Am Coll Surg. 2009;208:333-40.
18. Greene FL, Page DL, Fleming ID, et al. AJCC cancer staging handbook. TNM classification of malignant tumors, 6th edition. Springer, New York; 2002.
19. Woodward WA, Vinh-Hung V, Ueno NT, et al. Prognostic value of nodal ratios in node-positive breast cancer. J Clin Oncol. 2006;24:2910-6. (Pubitemid 46630594)
20. Vinh-Hung V, Verschraegen C, Promish DI, et al. Ratios of involved nodes in early breast cancer. Breast Cancer Res. 2004;6:680-8.
21. van der Wal BC, Butzelaar RM, van der Meij S, Boermeester MA. Axillary lymph node ratio and total number of removed lymph nodes: predictors of survival in stage I and II breast cancer. Eur J Surg Oncol. 2002;28:481-9.
22. Yildirim E, Berberoglu U. Lymph node ratio is more valuable than level III involvement for prediction of outcome in node-positive breast carcinoma patients. World J Surg. 2007;31:276-89.
23. Vinh-Hung V, Verkooijen HM, Pioretto G, et al. Lymph node ratio as an alternative to pN staging in node-positive breast cancer. J Clin Oncol. 2009;27:1062-8.
24. Kuru B. Prognostic significance of total number of nodes removed, negative nodes removed, and ratio of positive nodes to removed nodes in node positive breast carcinoma. Eur J Surg Oncol. 2006;32:1082-8.
25. Truong PT, Berthelet E, Lee J, Kader H, Olivotto IA. The prognostic significance of the percentage of positive/dissected axillary lymph nodes in breast cancer recurrence and survival in patients with one to three positive axillary lymph nodes. Cancer. 2005;103:2006-14. (Pubitemid 40605106)
26. Zhang H, Singer B. Statistics for biology and health: recursive partitioning in the health sciences. Springer, New York; 1999.
27. S-Plus 6 for Windows: Guide to Statistics, Volume 2. Insightful Corporation, Washington; 2001.
28. Lyman GH, Giuliano AE, Somerfield MR, et al. American Society of Clinical Oncology guideline recommendations for sentinel lymph node biopsy in early-stage breast cancer. J Clin Oncol. 2005;23:7703-20.
29. Veronesi U, Paganelli G, Viale G, et al. A randomized comparison of sentinel-node biopsy with routine axillary dissection in breast cancer. N Engl J Med. 2003;349:546-53.
30. Cserni G, Bianchi S, Boecker W, et al. Improving the reproducibility of diagnosing micrometastases and isolated tumor cells. Cancer. 2005;103:358-67.
31. Turner RR, Weaver DL, Cserni G, et al. Nodal stage classification for breast carcinoma: improving interobserver reproducibility through standardized histologic criteria and image-based training. J Clin Oncol. 2008;26:258-63.
32. Gillanders WE, Mikhitarian K, Hebert R, et al. Molecular detection of micrometastatic breast cancer in histopathology-negative axillary lymph nodes correlated with traditional predictors of prognosis: an interim analysis of a prospective multi-institutional cohort study. Ann Surg. 2004;239:828-37.
33. Olivotto IA, Bajdik CD, Ravdin PM, et al. Population-based validation of the prognostic model Adjuvant! for early breast cancer. J Clin Oncol. 2005;23:2716-25.
34. Cserni G, Gregori D, Merletti F, et al. Non-sentinel node metastases associated with micrometastatic sentinel nodes in breast cancer: metaanalysis of 25 studies. Br J Surg. 2004;91:1245-52. (Pubitemid 39331448)
35. Viale G, Maiorano E, Mazzarol G, et al. Histologic detection and clinical implications of micrometastases in axillary sentinel lymph nodes for patients with breast carcinoma. Cancer. 2001;92:1378-84.